View all news

    JANSSEN ANNOUNCES U.S. FDA APPROVAL OF STELARA® (USTEKINUMAB) FOR THE TREATMENT OF ADOLESCENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS

    10/13/2017
    Download(opens in new window)PDF 95 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com